Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02194842
Title Phase III Radium 223 mCRPC-PEACE III (PEACE III)
Recruitment Recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Indications

prostate adenocarcinoma

Therapies

Enzalutamide

Enzalutamide + Radium Ra 223 dichloride

Age Groups: adult | senior
Covered Countries ITA | FRA | ESP | CAN | BEL


No variant requirements are available.